This Voices of COVID story shares how Amanda Chawla, supply chain vice president, kept Stanford's health care workers protected when COVID-19 caused PPE shortages.
Tracking a pain-relief device's success in patients who aren't in clinical trials is seen as a promising approach to expanding treatment options for kids.
This Voices of COVID story features physician assistant Thanh Khong, who manages testing and vaccination operations for Stanford Health Care.
A partnership is improving patient care in the field of otolaryngology by pairing Stanford Biodesign fellows with clinicians.
Medical student Marcello Kendrew Chang shares the experience of a family caregiver he met during Stanford Medicine’s yearlong Walk With Me course.
This Voices of COVID piece features Charles Ayson, an experienced night-shift nurse on a COVID-19 unit, who is helping his team of nurses navigate the pandemic.
In the burgeoning field of pharmacogenetics, adhering to expert-developed guidelines is increasingly important, a Stanford Medicine physician emphasizes.
This Voices of COVID piece features nurse practitioner Kelly Sanderson, who is working to keep her patients healthy and her coworkers motivated.
This Voices of COVID story features Stanford Medicine PA student Zach West, who was a New York City 911 paramedic when COVID-19 hit.
Wearing caps labeled with names and roles made it easier for everyone in the operating room to communicate during C-sections, a Stanford study found.
In the first post in the Voices of COVID series, Andra Blomkalns and Alison Kerr share how the emergency medicine team is rising to the challenge of COVID.
A blood test that predicts if a baby will be born prematurely works well for pregnant women in developing countries, a Stanford-led study found.
A study from the Stanford Center for Biomedical Ethics shows wide variation in how hospitals interpret and implement patients’ end-of-life treatment wishes.
A public health program in India improved maternal and child health initially, but was at risk of leaving behind disadvantaged participants when it expanded.
A team in a Stanford Biodesign course that pairs computer science students with physicians developed an app designed to prompt end-of-life conversations.
Stanford Medicine researchers found that, based on genetic makeup, 99.5% of people are likely to have an atypical response to at least one drug.